Table-1.

Effects of M. crenata extract on luteinizing hormone and testosterone serum levels rats exposed to monosodium glutamate and treated with M. crenata extract (mean±standard deviation).

Groups	Luteinizing hormone levels (mIU.ml−1)		Testosterone levels (nmol.L−1)
	0 day	30 days	0 day	30 days
Control	8.89±0.44b	8.16±0.36c	8.03±0.36c	7.40±0.32b
MSG	7.54±0.19a	6.38±0.40a*	6.42±0.40a	4.33±0.64a*
MS1	7.42±1.64a	7.24±0.56b	6.13±0.82a	7.02±0.37b
MS2	7.43±0.73a	8.28±0.52c	6.87±0.54a	7.81±0.51b*
MS3	7.65±0.91a	8.67±0.62c*	6.97±0.70a	7.93±0.39b
S1	8.23±0.73b	8.47±0.58c	7.92±0.48b	8.27±0.69c
S2	8.40±0.67b	9.16±0.37d	7.75±0.54b	8.57±0.77c
S3	8.96±1.64b	9.97±0.21d	8.62±0.72c	7.06±0.64b

Different letters within the same column show a statistically significant (p<0.05). (*) Were indicated statistically significant between 0 days and 30 days based on paired samples T-test. The control group received 15 μL/200 g b.w. distilled water orally for 30 days; the MSG group received 4 mg/g b.w. of monosodium glutamate for 30 days; the MS1, MS2, and MS3 orally received with 4 mg/g b.w. of monosodium glutamate for 30 days and also orally received M. crenata extracts at different doses of 0.216 mg/g b.w., 0.432 mg/g b.w., and 0.648 mg/g b.w., respectively for 30 days; S1, S2, and S3 only orally received M. crenata extracts at doses of 0.216 mg/g b.w., 0.432 mg/g b.w., and 0.648 mg/g b.w., respectively, for 30 days. M. crenata=Marsilea crenata